The Synergistic Effect of Proanthocyanidin and HDAC Inhibitor Inhibit Breast Cancer Cell Growth and Promote Apoptosis

Histone deacetylase inhibitor (HDACi) is a drug mainly used to treat hematological tumors and breast cancer, but its inhibitory effect on breast cancer falls short of expectations. Grape seed proanthocyanidin extract (GSPE) with abundant proanthocyanidins (PAs) has been explored for its inhibition o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tsz Ki, Xu, Shaoting, Fan, Yuanjian, Wu, Jing, Wang, Zilin, Chen, Yue, Zhang, Yunjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341808/
https://www.ncbi.nlm.nih.gov/pubmed/37445654
http://dx.doi.org/10.3390/ijms241310476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341808/
https://www.ncbi.nlm.nih.gov/pubmed/37445654
http://dx.doi.org/10.3390/ijms241310476

Ejemplares similares